Multimodality imaging: Overview of imaging techniques (CT, MRI, PET, optical imaging) and impact of multimodality imaging on drug development

Trends on the Role of PET in Drug Development

Volumn , Issue , 2012, Pages 319-382

  Waerzeggers, Yannic ^a,b   Monfared, Parisa ^a   Ullrich, Roland ^a   Viel, Thomas ^a   Jacobs, Andreas H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84986582585     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814317740_0013     Document Type: Chapter

References (120)

1. Aime S, Dastru W, et al. Agents for polarization enhancement in MRI. Handb Exp Pharmacol 2008: 247-272.
2. Anderson SA, Glod J, et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005; 105: 420-425.
3. Badea CT, Hedlund LW, et al. Micro-CT with respiratory and cardiac gating. Med Phys 2004; 31: 3324-3329.
4. Badea CT, Fubara B, et al. 4-D Micro-CT of the mouse heart. Mol Imaging 2005;4:110-116.
5. Beckmann N, Schuler A, et al. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer’s disease. J Neurosci 2003; 23: 8453-8459.
6. Beckmann N, Kneuer R, et al. In vivo mouse imaging and spectroscopy in drug discovery. NMR Biomed 2007; 20: 154-185.
7. Bhattacharyya S, Wang S, et al. Synthesis and evaluation of near-infrared (NIR) dye-herceptin conjugates as photoacoustic computed tomography (PCT) probes for HER2 expression in breast cancer. Bioconjug Chem2008; 19: 1186-1193.
8. Bhaumik S, Lewis XZ, et al. Optical imaging of Renilla luciferase, synthetic Renilla luciferase, and firefly luciferase reporter gene expression in living mice. J Biomed Opt 2004; 9: 578-586.
9. Blankenberg FG. In vivo detection of apoptosis. J Nucl Med 2008; 49: 81S-95S.
10. Boone JM, Velazquez O, et al. Small-animal X-ray dose from micro-CT. Mol Imaging 2004; 3: 149-158.
11. Briat A, Vassaux G. Pre-clinical applications of imaging for cancer gene therapy. Expert Rev Mol Med 2006; 8: 1-19.
12. Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 2008a; 49:113S-128S.
13. Cai W, Niu G, et al. Multimodality imaging of the HER-kinase axis in cancer. Eur J Nucl Med Mol Imaging 2008b; 35: 186-208.
14. Cairns RA, Khokha R, et al. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003; 3: 659-671.
15. Cao F, Lin S, et al. In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006; 113: 1005-1014.
16. Carlsen H, Moskaug JO, et al. In vivo imaging of NF-kappa B activity. J Immunol 2002; 168: 1441-1446.
17. Chan CT, Paulmurugan R, et al. Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects. Cancer Res 2008; 68: 216-226.
18. Chen J, Tung CH, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105: 2766-2771.
19. Chen JW, Querol Sans M, et al. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 2006; 240: 473-481.
20. Chung YL, Troy H, et al. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. J Natl Cancer Inst 2003; 95: 1624-1633.
21. Ciana P, Raviscioni M, et al. In vivo imaging of transcriptionally active estrogen receptors. Nat Med. Jan 2003; 9(1):82-86.
22. Citrin D, Lee AK, et al. In vivo tumor imaging in mice with near-infrared labeled endostatin. Mol Cancer Ther 2004; 3: 481-488.
23. Cizek J, Herholz K, et al. Fast and robust registration of PET and MR images of human brain. Neuroimage 2004; 22: 434-442.
24. Coatney RW. Ultrasound imaging: principles and applications in rodent research. ILAR J 2001; 42: 233-247.
25. Dawson D, Lygate CA, et al. Quantitative 3-dimensional echocardiography for accurate and rapid cardiac phenotype characterization in mice. Circulation 2004; 110: 1632-1637.
26. De A, Gambhir SS. Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer. FASEB J 2005; 19: 2017-2019.
27. De A, Loening AM, et al. An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects. Cancer Res 2007; 67: 7175-7183.
28. De la Zerda A, Zavaleta C, et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008; 3: 557-562.
29. Deroose CM, De A, Loening AM, et al. Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J Nucl Med 2007; 48: 295-303.
30. Garofalakis A, Zacharakis G, et al. Three-dimensional in vivo imaging of green fluorescent protein-expressing T cells in mice with noncontact fluorescence molecular tomography. Mol Imaging 2007; 6: 96-107.
31. Goetz M, Kiesslich R, et al. In vivo confocal laser endomicroscopy of the human liver: a novel method for assessing liver microarchitecture in real time. Endoscopy 2008; 40: 554-562.
32. Griffin JL, Lehtimaki KK, et al. Assignment of 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res 2003; 63: 3195-3201.
33. Gross S, Piwnica-Worms D. Molecular imaging strategies for drug discovery and development. Curr Opin Chem Biol 2006; 10: 334-342.
34. Hamstra DA, Chenevert TL, et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 2005; 102: 16759-16764.
35. Heneka MT, Ramanathan M, et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 2006; 26: 1343-1354.
36. Higgins GA, Jacobsen H. Transgenic mouse models of Alzheimer’s disease: phenotype and application. Behav Pharmacol 2003; 14: 419-438.
37. Himmelreich U, Aime S, et al. A responsive MRI contrast agent to monitor functional cell status. Neuroimage 2006; 32: 1142-1149.
38. Hintersteiner M, Enz A, et al. In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe. Nat Biotechnol 2005;23: 577-583.
39. Hsu AR, Cai W, Veeravagu A, et al. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J Nucl Med 2007; 48: 445-454.
40. Hurlock GS, Higashino H, et al. History of cardiac computed tomography: single to 320-detector row multislice computed tomography. Int J Cardiovasc Imag. 2009; 25: 31-42.
41. Jacobs A, Voges J, et al. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001; 358: 727-729.
42. Jacobs AH, Rueger MA, et al. Imaging-guided gene therapy of experimental gliomas. Cancer Res 2007; 67: 1706-1715.
43. Jaffer FA, Nahrendorf M, et al. Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 2006; 5: 85-92.
44. Jaffer FA, Vinegoni C, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation 2008; 118: 1802-1809.
45. Jin ZH, Razkin J, et al. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4). Mol Imaging 2007; 6: 43-55.
46. Jouanneau E. Angiogenesis and gliomas: current issues and development of surrogate markers. Neurosurgery 2008; 62: 31-50.
47. Kanerva A, Zinn KR, et al. Noninvasive dual modality in vivo monitoring of the persistence and potency of a tumor targeted conditionally replicating adenovirus. Gene Ther 2005; 12: 87-94.
48. Kang H-W, Bogdanov AA. Imaging of noggin-induced tumor growth arrest in a human xenograft model. 2008 World Molecular Imaging Congress 2008; poster presentation 1196.
49. Keren S, Zavaleta C, et al. Noninvasive molecular imaging of small living subjects using Raman spectroscopy. Proc Natl Acad Sci USA 2008; 105: 5844-5849.
50. Kircher MF, Mahmood U, et al. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003; 63: 8122-8125.
51. Kurdziel KA, Kiesewetter DO, et al. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates. J Nucl Med 2003; 44: 1330-1339.
52. Kustermann E, Roell W, et al. Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed 2005; 18: 362-370.
53. Laws SM, Hone E, et al. Expanding the association between the APOE gene and the risk of Alzheimer’s disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003;84:1215-1236.
54. Laxman B, Hall DE, et al. Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 2002; 99: 16551-16555.
55. Li L, Zemp RJ, Lungu G, et al. Photoacoustic imaging of lacZ gene expression in vivo. JBiomed Opt 2007; 12: 020504.
56. Louie AY, Huber MM, et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 2000; 18: 321-325.
57. Magness ST, Jijon H, et al. In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol 2004; 173: 1561-1570.
58. Martinez-Bisbal MC, Arana E, et al. Cognitive impairment: classification by 1H magnetic resonance spectroscopy. Eur J Neurol 2004; 11: 187-193.
59. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545-580.
60. Massoud TF, Singh A, et al. Noninvasive molecular neuroimaging using reporter genes: part I, principles revisited. Am J Neuroradiol 2008; 29: 229-234.
61. McVeigh ER. Emerging imaging techniques. Circ Res 2006; 98: 879-886.
62. Menasche P. Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther 2009; 17: 758-766.
63. Miletic H, Fischer Y, et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 2007; 15: 1373-1381.
64. Miyawaki A, Sawano A, et al. Lighting up cells: labelling proteins with fluo-rophores. Nat Cell Biol 2003; Suppl: S1-S7.
65. Moffat BA, Chenevert TL, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 2005; 102: 5524-5529.
66. Monfared P, Winkeler A, Klein M, et al. Noninvasive assessment of E2F-1-mediated transcriptional regulation in vivo. Cancer Res 2008; 68: 5932-5940.
67. Mueggler T, Sturchler-Pierrat C, et al. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J Neurosci 2002; 22: 7218-7224.
68. Mukundan S, Jr., Ghaghada KB, et al. A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am J Roentgenol 2006; 186: 300-307.
69. Mulder WJ, Strijkers GJ, et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005; 19: 2008-2010.
70. Mulder WJ, Douma K, et al. Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn Reson Med 2006; 55: 1170-1174.
71. Mulder WJ, van der Schaft DW, et al. Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J 2007; 21: 378-383.
72. Muruganandham M, Lupu M, et al. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Mol Cancer Ther 2006; 5: 1950-1957.
73. Nahrendorf M, Jaffer FA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006; 114: 1504-1511.
74. Nahrendorf M, Sosnovik DE, et al. MR-optical imaging of cardiovascular molecular targets. Basic Res Cardiol 2008a; 103: 87-94.
75. Nahrendorf M, Zhang H, et al. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008b; 117: 379-387.
76. Neves AA, Brindle KM. Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta 2006; 1766: 242-261.
77. Ntziachristos V, Tung CH, et al. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med. Jul 2002; 8(7): 757-760.
78. Osborn EA, Jaffer FA. Advances in molecular imaging of atherosclerotic vascular disease. Curr Opin Cardiol 2008; 23: 620-628.
79. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002; 16: 407-422.
80. Peter JR, Ruehle H, et al. Development and initial results of a dualmodality SPECT/optical small animal imager. In: Nuclear Science Symposium Conference Record, 2005 IEEE (ed.) B. Yu. Puerto Rico 2005, pp.1969-1972.
81. Pichler BJ, Wehrl HF, et al. Latest advances in molecular imaging instrumentation. J Nucl Med 2008; 49: 5S-23S.
82. Pichlmeier U, Bink A, et al. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 2008; 10: 1025-1034.
83. Ray P, De A, et al. Imaging tri-fusion multimodality reporter gene expression in living subjects. Cancer Res 2004; 64: 1323-1330.
84. Rehemtulla A, Stegman LD, et al. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2000; 2: 491-495.
85. Rudin M, Mueggler T, et al. Characterization of CNS disorders and evaluation of therapy using structural and functional MRI. Anal Bioanal Chem 2003a; 377: 973-981.
86. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003b; 2: 123-131.
87. Rudin M, Rausch M, et al. Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods. Mol Imaging Biol 2005; 7: 5-13.
88. Schellenberger EA, Bogdanov A, Jr, et al. Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI. Mol Imaging 2002; 1: 102-107.
89. Schipper ML, Cheng Z, et al. microPET-based biodistribution of quantum dots in living mice. J Nucl Med 2007; 48: 1511-1518.
90. Schubert M, Gautam D, et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 2004; 101: 3100-3105.
91. Schweinhardt P, Bountra C, et al. Pharmacological FMRI in the development of new analgesic compounds. NMR Biomed 2006; 19: 702-711.
92. Shah K, Tang Y, et al. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 2003; 22: 6865-6872.
93. Shah K, Jacobs A, et al. molecular imaging of gene therapy for cancer. Gene Ther 2004; 11: 1175-1187.
94. Shah K, Bureau E, et al. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann Neurol2005; 57: 34-41.
95. Sibtain NA, Howe FA, et al. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol 2007; 62: 109-119.
96. Sipkins DA, Gijbels K, et al. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 2000; 104:1-9.
97. Soling A, Theiss C, et al. A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet Vaccines Ther 2004; 2: 7.
98. Sykova E, Vorisek I, et al. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer’s disease. Proc Natl Acad Sci USA 2005; 102: 479-484.
99. Tang TY, Howarth SP, et al. Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis. Stroke 2008; 39: 2144-2147.
100. Toyama H, Ye D, et al. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease. Eur J Nucl Med Mol Imaging 2005; 32: 593-600.
101. Vallee JP, Ivancevic MK, et al. Current status of cardiac MRI in small animals. Magn Reson Mater Phy 2004; 17: 149-156.
102. von Kienlin M, Kunnecke B, et al. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 2005; 18: 32-39.
103. Waerzeggers Y, Winkeler A, et al. Molecular-genetic imaging In: Molecular Imaging in Oncology (ed.) Pomper MG. New York: Informa Healthcare; 2008, pp. 443-468.
104. Waerzeggers Y, Jacobs AH, et al. Molecular imaging in patient-tailored cancer therapies. Eur Pharm Rev Dig 2009a; 3: 27-37.
105. Waerzeggers Y, Monfared P, et al. Methods to monitor gene therapy with molecular imaging. Methods 2009b; 48: 146-160.
106. Wang L, Xie X, et al. Combined photoacoustic and molecular fluorescence imaging in vivo. Conf Proc IEEE Eng Med Biol Soc 2005; 1: 190-192.
107. Wang G, Cong W, Shen H, Qian X, Henry M, Wang Y. Overview of bioluminescence tomography — a new molecular imaging modality. Front Biosci 2008; 13: 1281-1293.
108. Wang LV. Prospects of photoacoustic tomography. Med Phys 2008; 35: 5758-5767.
109. Wieben O, Francois C, et al. Cardiac MRI of ischemic heart disease at 3 T: potential and challenges. Eur J Radiol 2008; 65: 15-28.
110. Willmann JK, van Bruggen N, et al. Molecular imaging in drug development. Nat Rev Drug Discov 2008a; 7: 591-607.
111. Willmann JK, Lutz AM, et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology 2008b; 248: 936-944.
112. Willmann JK, Cheng Z, et al. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology 2008c; 249: 212-219.
113. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123-128.
114. Welzel J. Optical coherence tomography in dermatology: a review. Skin Res Technol 2001; 7: 1-9.
115. Wu JC, Chen IY, et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 2003; 108: 1302-1305.
116. Wu JC, Bengel FM, et al. Cardiovascular molecular imaging. Radiology 2007;244: 337-355.
117. Yang Z, Zheng S, et al. Long-circulating near-infrared fluorescence corecross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules 2007; 8: 3422-3428.
118. Zhang W, Purchio AF, et al. A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene. Drug Metab Dispos 2003; 31: 1054-1064.
119. Zhang HF, Maslov K, et al. Functional photoacoustic microscopy for highresolution and noninvasive in vivo imaging. Nat Biotechnol 2006; 24: 848-851.
120. Zhao M, Beauregard DA, et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 2001; 7: 1241-1244.